Results
26,453 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 39 |  Ruemmler Kathryn H.Chief Legal Officer, GC |  GSGOLDMAN SACHS GROUP INCOpen-market sale | SELL | $56K 60 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 39 | Ruemmler Kathryn H.Chief Legal Officer, GC | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $56K 60 sh |
| Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $115K 124 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $126K 136 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Ruemmler Kathryn H.Chief Legal Officer, GC | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $167K 178 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $192K 208 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $155K 167 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $241K 262 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 37 | Phelan Kenneth JDirector |  JHSJOHN HANCOCK INCOME SECURITIES TRUSTOpen-market purchase | BUY | $8,541 725 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 36 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $11K 12 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 36 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $37K 40 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 36 | Alam KamranCHIEF FINANCIAL OFFICER |  TSHATaysha Gene Therapies, Inc.Open-market sale | SELL | $375K 79.0K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 36 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $9,360 10 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 34 | Howe JolandaSVP, GLOBAL CONTROLLER |  MIRMMirum Pharmaceuticals, Inc.Open-market sale | SELL | $81K 842 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 33 | Banks Margaret KatherineDirector |  HALHALLIBURTON COOpen-market sale | SELL | $89K 2,600 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 33 | Whitley Laura LDirector |  TCBITEXAS CAPITAL BANCSHARES INC/TXOpen-market purchase | BUY | $49K 500 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 32 | Nagendran SukumarDirector, President and Head of R&D | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $423K 89.1K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 30 | Walsh John FCEO-The Americas |  ACNAccenture plcOpen-market sale · 10b5-1 plan | SELL | $718K 2,600 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 30 | Kuffner JamesCHIEF TECHNOLOGY OFFICER |  SYMSymbotic Inc.Open-market sale | SELL | $63K 1,048 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 29 | Whitley Laura LDirector | TCBITEXAS CAPITAL BANCSHARES INC/TX Open-market purchase | BUY | $49K 500 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 25 | Nagendran SukumarDirector, President and Head of R&D | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $124K 26.9K sh | Jan 27, 2026 traded Jan 26, 2026 |
| 25 | Alam KamranCHIEF FINANCIAL OFFICER | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $110K 23.8K sh | Jan 27, 2026 traded Jan 26, 2026 |
| 24 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.56M 51.9K sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $119K 429 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $117K 421 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $144K 524 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $74K 263 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $64K 227 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 22 | A-6684 Ltd.10% Owner |  TOFBTOFUTTI BRANDS INCOpen-market purchase | BUY | $3,439 4,525 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 20 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $3,360 12 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $145K 514 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $17K 62 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $283 1 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $30K 107 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 18 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $244K 8,135 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 15 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $360K 12.1K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $8,904 32 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $47K 168 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $20K 71 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $567 2 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $364K 2,663 sh | Jan 27, 2026 traded Jan 26, 2026 |